Skip to content

Author

Shi-Qiang Hou

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

In Vivo Immunoscoring Technique to Monitor Anti-CD47 Immunotherapy Efficacy in Triple-Negative Breast Cancer.

BACKGROUND Phagocytosis checkpoints, such as CD47, have emerged as promising targets for cancer immunotherapy and are being investigated in clinical trials. Despite encouraging findings, reliable biomarkers for monitoring immunotherapeutic responses in triple-negative breast cancer (TNBC) remain tracking. OBJECTIVE T...

Min-Feng Yang, Shi-Qiang Hou, Chi-Ming Wong et al. · 0 citations
Open access Sep 2026

Integrated Pan-Cancer, Single-Cell, and Spatial Transcriptomic Analyses Identify ZDHHC12 as a Biomarker Associated with Macrophage Infiltration and the Immune Landscape in Glioma

ZDHHC12 may serve as a candidate pan-cancer prognostic biomarker and its expression was broadly correlated with immune cell recruitment- and activation-related signatures in glioma and in glioma, and was associated with patient prognosis.

Chao Zhang, Da Teng, Yu Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.